"Herpesvirus 3, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans.
| Descriptor ID |
D014645
|
| MeSH Number(s) |
B04.280.382.100.900.460
|
| Concept/Terms |
Herpesvirus 3, Human- Herpesvirus 3, Human
- Human Herpesvirus 3
- Chickenpox Virus
- Chickenpox Viruses
- Herpes zoster Virus
- Herpes zoster Viruses
- HHV-3
- Varicella-Zoster Virus
- Varicella Zoster Virus
- Varicella-Zoster Viruses
- Herpesvirus 3 (alpha), Human
- VZ Virus
- VZ Viruses
- Herpesvirus Varicellae
- Varicellae, Herpesvirus
- Ocular Herpes zoster Virus
|
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 3, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 3, Human".
This graph shows the total number of publications written about "Herpesvirus 3, Human" by people in this website by year, and whether "Herpesvirus 3, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 2 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 4 | 0 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Herpesvirus 3, Human" by people in Profiles.
-
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
-
Herpes zoster diagnosis and treatment in relation to incident dementia: A population-based retrospective matched cohort study. PLoS One. 2024; 19(1):e0296957.
-
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ. 2023 Nov 08; 383:e076321.
-
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine. Vaccine. 2023 Jul 05; 41(30):4392-4401.
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 Feb 01; 192(2):205-216.
-
Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
-
Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus. Virology. 2020 07; 546:38-50.
-
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine. 2019 06 06; 37(26):3478-3484.
-
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. J Infect Dis. 2017 12 12; 216(11):1343-1351.
-
Family history of zoster and risk of developing herpes zoster. Int J Infect Dis. 2018 Jan; 66:99-106.